Rick Murdock

Rick Murdock

Chairman at Open Monoclonal Technology, Inc.

Health Technology
Health Services
Consumer Services

Profile

Richard D.
Murdock
is currently the Chairman of Open Monoclonal Technology, Inc., Director of ODC Therapy, Inc., and Director of TeneoBio, Inc. Previously, he served as Chairman & CEO of SangStat Medical Corp., President & CEO of Medtronic Spine LLC, and President & CEO of CellPro, Inc. He also held positions as Principal at Baxter International, Jazz Pharmaceuticals (EUSA Pharma USA), and Haemonetics Corp.
Murdock received his undergraduate degree from the University of California, Berkeley.

Rick Murdock active positions

CompaniesPositionStart
Director/Board Member 13/06/2006
Chairman 23/03/2010
Director/Board Member -
All active positions of Rick Murdock

Former positions of Rick Murdock

CompaniesPositionEnd
Chief Executive Officer 01/07/2001
HAEMONETICS CORPORATION Corporate Officer/Principal -
BAXTER INTERNATIONAL INC. Corporate Officer/Principal -
Corporate Officer/Principal -
CellPro, Inc. Chief Executive Officer -
See the detail of Rick Murdock's experience

Training of Rick Murdock

University of California, Berkeley Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Rick Murdock's experience

Connections

29

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
BAXTER INTERNATIONAL INC.

Health Technology

HAEMONETICS CORPORATION

Health Technology

Private companies7

Health Technology

SangStat Medical Corp.

Health Technology

Health Technology

Health Services

CellPro, Inc.

Health Technology

Health Technology

Commercial Services

See company connections